profit from every ₹100 of sales.
₹0₹100
Aster DM Healthcare
₹733.60-2.31% today
+18.2% in 1 year
1-year low ₹538.401-year high ₹870.30
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay ₹11.88 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Aster DM Healthcare sold, what it kept, and what it did with the cash.
Sales went from ₹103 billion in 2022 to ₹40.7 billion in 2025, with ₹53.8 billion of profit last year.
SalesProfit
Aster DM Healthcare handed back more cash to shareholders than it generated last year.
₹61.7B
Free cash flow 2025₹683M
Bought back its own shares–
Paid as dividends₹61.7B
Cash vs. debt₹1.6B vs. ₹20.2B
Aster DM Healthcare vs. similar companies
Aster DM Healthcare grows the slowest of these 5 and is the cheapest for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Aster DM Healthcare | 11.9× · Cheap | ||
 HCA Healthcare | 15.5× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.4× · Fair price | ||
 IHH Healthcare Berhad | 33.3× · Expensive | ||
 Rede D'Or São Luiz | 15.7× · Fair price |
AI analysis
An AI analyst reads Aster DM Healthcare's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 102,533 | 29,518 | 36,382 | 40,694 | |
| 73,615 | 21,677 | 27,223 | 31,310 | |
| 8,427 | 2,658 | 3,670 | 5,255 | |
| 15,345 | 10,611 | 13,550 | 8,333 | |
| 5,260 | 4,249 | 1,293 | 53,778 | |
| 10.57 | 8.53 | 2.60 | 107.85 | |
| 71.8% | 73.4% | 74.8% | 76.9% | |
| 8.2% | 9.0% | 10.1% | 12.9% | |
| 5.1% | 14.4% | 3.6% | 132.2% |
Balance sheet
| In millions of INR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 125,462 | 148,812 | 179,913 | 66,064 |
| Cash | 3,434 | 3,785 | 822 | 1,646 |
| Total debt | 49,071 | 57,003 | 13,838 | 20,178 |
| Total liabilities | 80,636 | 100,207 | 129,612 | 29,549 |
| 39,534 | 44,481 | 45,598 | 34,281 | |
| 498 | 498 | 498 | 499 | |
| 8.0% | 2.2% | 4.9% | 8.4% | |
| 13.3% | 9.6% | 2.8% | 156.9% |
Cash flow
| In millions of INR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 13,140 | 18,340 | 1,578 | 4,251 | |
| 5,480 | 8,479 | 8,056 | 3,567 | |
| 7,661 | 9,861 | -6,478 | 683 | |
| Dividends paid | – | – | – | 61,732 |
| – | – | – | – | |
| -1 | 7 | 74 | 84 |
Valuation
- 11.9×
- –
- 0.10
- 12.3×
- 15.7×
- 934.9×
- 78.9×
- 0.1%
- 8.4%
- 9.7%
Profitability
- 76.9%
- 12.9%
- 132.2%
- –
- 8.0%
- 5.6%
- –
- –
- –
- –
Growth
- −26.5%
- +116.9%
- –
- –
- +0.1%
Financial health
- 2.2×
- 0.59
- –
- 5.4×
- 2.16
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 38%of 948
Top 40%of 871
Top 13%of 560
Bottom 4%of 868
Bottom 42%of 985
9.7%of the share price, paid each year
On $1,000 invested$97a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
114.8% of its profit
Room to growStretchedMore than it earns: 9,035.8%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
43No pass
Benjamin Graham
65Pass
Philip Fisher
62Pass
Peter Lynch
83Pass
Joel Greenblatt
16No pass
Charlie Munger
52No pass
Terry Smith
43No pass
Questions about Aster DM Healthcare
Is Aster DM Healthcare a good stock to buy?
A strong, very profitable business, and the price looks low. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Aster DM Healthcare AI analysis
What does Aster DM Healthcare do?
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It is in Medical Care Facilities, based in Bengaluru, India.
Does Aster DM Healthcare pay a dividend?
Yes. At today's price the dividend is 9.7% a year, about 115% of its yearly profit. In 2025 it paid out ₹61.7 billion in dividends.
Is Aster DM Healthcare stock halal?
Yes. Aster DM Healthcare passes our halal screen: its business is permitted and its debt is 3% of its market value, under the 30% limit. How we check
How has Aster DM Healthcare stock done over the past year?
Up 18.2% over the past twelve months, to ₹733.60. It traded between ₹538.40 and ₹870.30 and is 15.7% below its high.
Who are Aster DM Healthcare's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Aster DM Healthcare's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.